Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-07-05 Purchase | 2024-08-23 1:54 pm | Nordicus Partners Corp | NORD | GK Partners ApS 10% Owner | 281,555 | $1 | $281,555 | 22,420,551 (Direct) | View |
| 2024-04-29 Purchase | 2024-06-04 4:52 pm | Nordicus Partners Corp | NORD | GK Partners ApS 10% Owner | 60,000 | $1 | $60,000 | 42,488,168 (Direct) | View |
| 2023-09-08 Purchase | 2024-03-26 4:12 pm | Nordicus Partners Corp | NORD | GK Partners ApS 10% Owner | 984,500 | $1 | $984,500 | 2,216,044 (Direct) | View |
| 2024-01-15 Sale | 2024-03-26 4:12 pm | Nordicus Partners Corp | NORD | GK Partners ApS 10% Owner | 1,701,527 | $0.97 | $1,650,481 | 2,216,044 (Direct) | View |
| 2024-03-20 Sale | 2024-03-26 3:35 pm | Nordicus Partners Corp | NORD | Rouf Henrik CEO | 250,000 | $1 | $250,000 | 585,018 (Direct) | View |
| 2023-02-28 Purchase | 2023-09-13 2:27 pm | Nordicus Partners Corp | NORD | GK Partners ApS 10% Owner | 4,903,618 | $0.99318 | $4,870,184 | 5,510,310 (Direct) | View |
| 2022-11-28 Sale | 2023-09-13 2:27 pm | Nordicus Partners Corp | NORD | GK Partners ApS 10% Owner | 5,722,786 | $0.84967 | $4,862,497 | 5,510,310 (Direct) | View |
| 2022-04-18 Purchase | 2023-08-08 09:29 am | Nordicus Partners Corp | NORD | Rouf Henrik CEO 10% Owner | 356,400 | $0.86798 | $309,349 | 1,970,036 (Indirect Direct) | View |
| 2023-01-21 Sale | 2023-06-23 06:09 am | Nordicus Partners Corp | NORD | Oerbekker Henrik Former 10% shareholder | 500,000 | $0.5 | $250,000 | 278,618 (Direct) | View |
| 2022-05-17 Purchase | 2022-06-27 8:27 pm | EKIMAS Corp | ASNB | Rouf Henrik 10% Owner | 4,335,857 | $0.03283 | $142,367 | 778,618 (Indirect) | View |
| 2022-03-17 Purchase | 2022-03-21 10:35 am | EKIMAS Corp | ASNB | Rouf Henrik 10% Owner | 4,691,750 | $0.0426 | $199,869 | 5,114,475 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-06-05 4:51 pm | N/A N/A | Nordicus Partners Corp | NORD | Alteral Therapeutics ApS 10% Owner | 0 | $0 | 12,652,279 (Direct) | View |
| 2024-05-14 Other | 2024-06-04 4:52 pm | N/A N/A | Nordicus Partners Corp | NORD | GK Partners ApS 10% Owner | 20,106,062 | $1 | 42,488,168 (Direct) | View |
| 2023-02-14 Exercise | 2023-09-13 2:27 pm | N/A N/A | Nordicus Partners Corp | NORD | GK Partners ApS 10% Owner | 195,000 | $1 | 5,510,310 (Direct) | View |
| 2022-08-23 Gift | 2023-08-31 10:41 am | N/A N/A | Nordicus Partners Corp | NORD | Rouf Henrik CEO | 100,000 | $0 | 835,018 (Direct) | View |
Ownership | 2022-09-08 2:25 pm | N/A N/A | EKIMAS Corp | ASNB | Oerbekker Henrik 10% Owner | 0 | $0 | 778,618 (Direct) | View |
Ownership | 2022-07-21 10:56 am | N/A N/A | EKIMAS Corp | ASNB | Gk Partners ApS 10% Owner | 0 | $0 | 3,557,239 (Direct) | View |
Ownership | 2021-10-18 1:50 pm | N/A N/A | EKIMAS Corp | ASNB | Rouf Henrik 10% Owner | 0 | $0 | 25,570,490 (Indirect) | View |
| 2019-12-05 Exercise | 2019-12-06 6:43 pm | N/A N/A | AdvanSource Biomaterials Corp | ASNB | Carroll Khristine L SVP | 950,000 | $0 | 1,335,309 (Direct) | View |
| 2019-12-05 Exercise | 2019-12-06 6:43 pm | N/A N/A | AdvanSource Biomaterials Corp | ASNB | Carroll Khristine L SVP | 100,000 | $0.06 | 1,335,309 (Direct) | View |
| 2019-12-05 Exercise | 2019-12-06 6:23 pm | N/A N/A | AdvanSource Biomaterials Corp | ASNB | BARRETTI MICHAEL L Director | 25,000 | $0.06 | 550,115 (Direct) | View |
| 2019-12-05 Exercise | 2019-12-06 6:17 pm | N/A N/A | AdvanSource Biomaterials Corp | ASNB | ONEILL WILLIAM J JR Director | 25,000 | $0.06 | 550,000 (Direct) | View |
| 2019-12-05 Exercise | 2019-12-06 6:10 pm | N/A N/A | AdvanSource Biomaterials Corp | ASNB | TAUSCHER MARK R Director | 350,000 | $0 | 400,000 (Direct) | View |
| 2019-12-05 Exercise | 2019-12-06 6:10 pm | N/A N/A | AdvanSource Biomaterials Corp | ASNB | TAUSCHER MARK R Director | 50,000 | $0.06 | 400,000 (Direct) | View |
| 2019-12-05 Exercise | 2019-12-06 5:56 pm | N/A N/A | AdvanSource Biomaterials Corp | ASNB | BARRETTI MICHAEL L Director | 525,000 | $0 | 525,115 (Direct) | View |
| 2019-12-05 Exercise | 2019-12-06 5:46 pm | N/A N/A | AdvanSource Biomaterials Corp | ASNB | ONEILL WILLIAM J JR Director | 525,000 | $0 | 525,000 (Direct) | View |
| 2019-12-05 Exercise | 2019-12-06 5:18 pm | N/A N/A | AdvanSource Biomaterials Corp | ASNB | ADAMS MICHAEL F CEO | 291,667 | $0 | 3,284,934 (Direct) | View |
| 2019-12-05 Exercise | 2019-12-06 5:18 pm | N/A N/A | AdvanSource Biomaterials Corp | ASNB | ADAMS MICHAEL F CEO | 2,383,333 | $0.06 | 3,284,934 (Direct) | View |